A 62-year-old man with a 40 pack-year smoking history and COPD presents with progressive dyspnea and cough. He is being considered for long-term oxygen therapy. What is the most common indication for initiating long-term oxygen therapy in COPD patients?

Explanation

## Indications for Long-Term Oxygen Therapy in COPD **Key Point:** Long-term oxygen therapy (LTOT) is indicated when PaO₂ falls below 55 mmHg or SpO₂ drops below 88% at rest on room air, measured on at least two occasions 3 weeks apart. ### Criteria for LTOT Initiation | Criterion | PaO₂ (mmHg) | SpO₂ (%) | Clinical Context | |-----------|------------|---------|------------------| | **Primary indication** | < 55 | < 88 | At rest, room air | | **Secondary indication** | 55–60 | 88–89 | With cor pulmonale, polycythemia, or pulmonary hypertension | | **Exercise hypoxemia** | < 55 during activity | < 88 during activity | If symptomatic desaturation | | **Sleep hypoxemia** | < 55 during sleep | < 88 during sleep | If significant nocturnal desaturation | **High-Yield:** The landmark NOTT (Nocturnal Oxygen Therapy Trial) and MRC (Medical Research Council) trials established that continuous LTOT (≥15 h/day) improves survival in COPD patients with resting hypoxemia (PaO₂ < 55 mmHg). This is the most common and most evidence-based indication. **Clinical Pearl:** Many COPD patients have borderline hypoxemia (PaO₂ 55–60 mmHg). In these cases, LTOT is indicated only if there is evidence of cor pulmonale, polycythemia (Hb > 15.5 g/dL), or pulmonary hypertension on echocardiography. **Mnemonic:** **LTOT 55** — Long-Term Oxygen Therapy indicated when PaO₂ is 55 or less (or SpO₂ ≤ 88%).